Adocam 1.5 mg/ml oral suspension for dogs

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Meloxicam

Available from:

aniMedica GmbH

ATC code:

QM01AC06

INN (International Name):

Meloxicam

Dosage:

1.5 milligram(s)/millilitre

Pharmaceutical form:

Oral suspension

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Dogs

Therapeutic area:

meloxicam

Therapeutic indications:

N.S.A.I.D.

Authorization status:

Authorised

Authorization date:

2015-04-10

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Adocam 1.5 mg/ml oral suspension for dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml of product contains:
Active substance(s):
Meloxicam 1.5 mg (equivalent to 0.05 mg per drop)
Excipient(s):
Sodium benzoate 1.5 mg (equivalent to 0.05 mg per drop)
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
The product is a pale yellow viscous suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dog.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Alleviation of inflammation and pain in both acute and chronic
musculo-skeletal disorders.
4.3 CONTRAINDICATIONS
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such
as irritation and haemorrhage, impaired hepatic,
cardiac or renal function and haemorrhagic disorders.
Do not use in cases of known hypersensitivity to the active substance
or to any of the excipients
Do not use in dogs less than 6 weeks of age.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_0_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_0_
_6_
_4_
_1_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
If adverse reactions occur, treatment should be discontinued and the
advice of a veterinarian should be sought.
Avoid use in any dehydrated, hypovolaemi